Alpha Tau Medical Ltd. (DRTSW) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Jerusalem, Israel. The current CEO is Uzi Sofer.
DRTSW has 125 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $82.72M.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.
